ECC-话题@MedSci

#ECC#

39篇内容 | 1656人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1954201, encodeId=59701954201b2, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECCMID 2016：与手术相关的预防性抗生素使用并不是越久越好, objectType=article, longId=66542, objectId=bfdb6654278, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfdb6654278, replyNumber=0, likeNumber=68, createdTime=2017-02-07, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfdb6654278, moduleTitle=ECCMID 2016：与手术相关的预防性抗生素使用并不是越久越好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfdb6654278)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954202, encodeId=e8a619542025c, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=OCC 2016：2015心肺复苏（CPR）和心血管急救（ECC）指南更新要点, objectType=article, longId=69427, objectId=d3a16942e63, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a16942e63, replyNumber=0, likeNumber=66, createdTime=2017-03-30, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a16942e63, moduleTitle=OCC 2016：2015心肺复苏（CPR）和心血管急救（ECC）指南更新要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a16942e63)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954203, encodeId=86b019542035d, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=J Clin Oncol：直肠癌新辅助放化疗后接受手术的更佳时间？ 7周or11周？ (GRECCAR-6), objectType=article, longId=73392, objectId=8082e339282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8082e339282, replyNumber=0, likeNumber=73, createdTime=2017-05-24, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8082e339282, moduleTitle=J Clin Oncol：直肠癌新辅助放化疗后接受手术的更佳时间？ 7周or11周？ (GRECCAR-6), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8082e339282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954204, encodeId=f91c195420441, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=2016ECCO欧洲循证共识——克罗恩病的诊断管理发布, objectType=article, longId=78703, objectId=95e7e87031b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95e7e87031b, replyNumber=0, likeNumber=73, createdTime=2017-06-28, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95e7e87031b, moduleTitle=2016ECCO欧洲循证共识——克罗恩病的诊断管理发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95e7e87031b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954199, encodeId=da7a19541995b, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECCO 2016：粪便微生物移植解决难治性溃疡性结肠炎, objectType=article, longId=66107, objectId=35346610e27, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35346610e27, replyNumber=0, likeNumber=68, createdTime=2016-07-20, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35346610e27, moduleTitle=ECCO 2016：粪便微生物移植解决难治性溃疡性结肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35346610e27)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954196, encodeId=560919541966d, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECC 2015：口服长春瑞滨——NSCLC和ABC患者的一线治疗新选择？, objectType=article, longId=56827, objectId=e9485682e00, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9485682e00, replyNumber=0, likeNumber=63, createdTime=2016-08-21, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9485682e00, moduleTitle=ECC 2015：口服长春瑞滨——NSCLC和ABC患者的一线治疗新选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9485682e00)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954200, encodeId=84421954200f8, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECCMID 2016：Omadacycline是安全有效的皮肤感染治疗药物, objectType=article, longId=66538, objectId=9ec266538a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ec266538a3, replyNumber=0, likeNumber=67, createdTime=2017-03-05, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ec266538a3, moduleTitle=ECCMID 2016：Omadacycline是安全有效的皮肤感染治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ec266538a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954193, encodeId=85921954193a1, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECC 2015：阿司匹林抗癌效果突出，肿瘤患者生存时长可翻倍, objectType=article, longId=56819, objectId=87705681910, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87705681910, replyNumber=0, likeNumber=73, createdTime=2016-05-17, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87705681910, moduleTitle=ECC 2015：阿司匹林抗癌效果突出，肿瘤患者生存时长可翻倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87705681910)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954194, encodeId=34ba1954194ff, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECC 2015：奥曲肽联合177Lu—DOTATATE对神经内分泌肿瘤可能有效（NETTER-1研究）, objectType=article, longId=56825, objectId=2bd2568257c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bd2568257c, replyNumber=0, likeNumber=56, createdTime=2016-04-29, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bd2568257c, moduleTitle=ECC 2015：奥曲肽联合177Lu—DOTATATE对神经内分泌肿瘤可能有效（NETTER-1研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bd2568257c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954197, encodeId=3930195419e97, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECC 2015：早期乳腺癌研究进展精选, objectType=article, longId=56871, objectId=6644568e147, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6644568e147, replyNumber=0, likeNumber=67, createdTime=2016-06-07, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6644568e147, moduleTitle=ECC 2015：早期乳腺癌研究进展精选, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6644568e147)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954195, encodeId=27bc19541954f, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECC 2015：依维莫司能显著延长无功能的胃肠道和肺神经内分泌肿瘤（RADIANT-4研究）, objectType=article, longId=56826, objectId=b5ff56826ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5ff56826ae, replyNumber=0, likeNumber=82, createdTime=2016-04-09, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5ff56826ae, moduleTitle=ECC 2015：依维莫司能显著延长无功能的胃肠道和肺神经内分泌肿瘤（RADIANT-4研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5ff56826ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954198, encodeId=e08b195419884, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECC 2015：晚期肺鳞癌治疗进展, objectType=article, longId=56879, objectId=4285568e9e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4285568e9e2, replyNumber=0, likeNumber=62, createdTime=2015-11-04, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4285568e9e2, moduleTitle=ECC 2015：晚期肺鳞癌治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4285568e9e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954192, encodeId=9664195419226, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=美国新英格配制中心（NECC）事件的教训和反思, objectType=article, longId=46228, objectId=75f34622831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75f34622831, replyNumber=0, likeNumber=0, createdTime=2015-08-02, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75f34622831, moduleTitle=美国新英格配制中心（NECC）事件的教训和反思, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75f34622831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954191, encodeId=77451954191f5, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECCMID 2014 ：头孢洛林对亚洲社区获得性肺炎患者疗效较佳, objectType=article, longId=35804, objectId=03203580490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03203580490, replyNumber=0, likeNumber=66, createdTime=2015-03-22, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03203580490, moduleTitle=ECCMID 2014 ：头孢洛林对亚洲社区获得性肺炎患者疗效较佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03203580490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954190, encodeId=66841954190d3, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=Lancet Oncol：帕尼单抗对KRAS野生型转移性结直肠癌非劣于西妥昔单抗（ASPECCT研究）, objectType=article, longId=33909, objectId=cae8339099f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cae8339099f, replyNumber=0, likeNumber=66, createdTime=2014-12-30, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cae8339099f, moduleTitle=Lancet Oncol：帕尼单抗对KRAS野生型转移性结直肠癌非劣于西妥昔单抗（ASPECCT研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cae8339099f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954187, encodeId=d7bd195418eeb, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECC 2013辩论场：PFS是有效的主要终点吗？, objectType=article, longId=25642, objectId=34db25642d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34db25642d9, replyNumber=0, likeNumber=66, createdTime=2014-05-27, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34db25642d9, moduleTitle=ECC 2013辩论场：PFS是有效的主要终点吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34db25642d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954189, encodeId=e8ea1954189f4, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECC 2013：转移性黑色素瘤治疗的重大进展, objectType=article, longId=29036, objectId=4128290361f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4128290361f, replyNumber=0, likeNumber=56, createdTime=2014-01-25, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4128290361f, moduleTitle=ECC 2013：转移性黑色素瘤治疗的重大进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4128290361f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954188, encodeId=f2b81954188a4, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECC 2013：Brentuximab或为晚期霍奇金淋巴瘤标准一线治疗, objectType=article, longId=28908, objectId=c44e2890809, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c44e2890809, replyNumber=0, likeNumber=79, createdTime=2014-01-14, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c44e2890809, moduleTitle=ECC 2013：Brentuximab或为晚期霍奇金淋巴瘤标准一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c44e2890809)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954186, encodeId=a5e01954186d2, content=<a href='/topic/show?id=3eb664e988' target=_blank style='color:#2F92EE;'>#ECC#</a>, objectTitle=ECCMID 2011：感染性疾病机制研究新动态, objectType=article, longId=2619, objectId=694d26193d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=694d26193d, replyNumber=0, likeNumber=60, createdTime=2012-02-19, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=694d26193d, moduleTitle=ECCMID 2011：感染性疾病机制研究新动态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=694d26193d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ECC

2020-05-29

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECCMID 2016：与手术相关的预防性抗生素使用并不是越久越好

2017-02-07

仁医06 (审核中...)

前往app查看评论内容

#ECC#

OCC 2016：2015心肺复苏（CPR）和心血管急救（ECC）指南更新要点

2017-03-30

仁医06 (审核中...)

前往app查看评论内容

#ECC#

J Clin Oncol：直肠癌新辅助放化疗后接受手术的更佳时间？ 7周or11周？ (GRECCAR-6)

2017-05-24

仁医06 (审核中...)

前往app查看评论内容

#ECC#

2016ECCO欧洲循证共识——克罗恩病的诊断管理发布

2017-06-28

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECCO 2016：粪便微生物移植解决难治性溃疡性结肠炎

2016-07-20

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECC 2015：口服长春瑞滨——NSCLC和ABC患者的一线治疗新选择？

2016-08-21

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECCMID 2016：Omadacycline是安全有效的皮肤感染治疗药物

2017-03-05

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECC 2015：阿司匹林抗癌效果突出，肿瘤患者生存时长可翻倍

2016-05-17

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECC 2015：奥曲肽联合177Lu—DOTATATE对神经内分泌肿瘤可能有效（NETTER-1研究）

2016-04-29

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECC 2015：早期乳腺癌研究进展精选

2016-06-07

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECC 2015：依维莫司能显著延长无功能的胃肠道和肺神经内分泌肿瘤（RADIANT-4研究）

2016-04-09

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECC 2015：晚期肺鳞癌治疗进展

2015-11-04

仁医06 (审核中...)

前往app查看评论内容

#ECC#

美国新英格配制中心（NECC）事件的教训和反思

2015-08-02

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECCMID 2014 ：头孢洛林对亚洲社区获得性肺炎患者疗效较佳

2015-03-22

仁医06 (审核中...)

前往app查看评论内容

#ECC#

Lancet Oncol：帕尼单抗对KRAS野生型转移性结直肠癌非劣于西妥昔单抗（ASPECCT研究）

2014-12-30

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECC 2013辩论场：PFS是有效的主要终点吗？

2014-05-27

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECC 2013：转移性黑色素瘤治疗的重大进展

2014-01-25

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECC 2013：Brentuximab或为晚期霍奇金淋巴瘤标准一线治疗

2014-01-14

仁医06 (审核中...)

前往app查看评论内容

#ECC#

ECCMID 2011：感染性疾病机制研究新动态

2012-02-19

科室
- - 订阅+
  - 更多科室
工具
服务